INTERNATIONAL PATENT: CORVUS PHARMACEUTICALS, INC. FILES APPLICATION FOR "INTERLEUKIN-2-INDUCIBLE T-CELL KINASE INHIBITORS TO PRODUCE ENHANCED IMMUNE RESPONSES"

GENEVA, April 30 -- CORVUS PHARMACEUTICALS, INC. (863 Mitten Road, Suite 102Burlingame, CA 94010) filed a patent application (PCT/US2024/052200) for "INTERLEUKIN-2-INDUCIBLE T-CELL KINASE INHIBITORS TO PRODUCE ENHANCED IMMUNE RESPONSES" on Oct 21, 2024. With publication no. WO/2025/085889, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MILLER, Richard A. (863 Mitten Road, Suite 102Burlingame, CA 94010), HSU, Lih-Yun (863 Mitten Road, Suite 102Burlingame, CA 94010)

Abstract: Provided are, inter alia, vaccines comprisin...